Ex Vivo Expanded Donor Alloreactive Regulatory T Cells Lose Immunoregulatory, Proliferation, and Antiapoptotic Markers After Infusion Into ATG-lymphodepleted, Nonhuman Primate Heart Allograft Recipients

被引:17
作者
Ezzelarab, Mohamed B. [1 ]
Zhang, Hong [1 ]
Sasaki, Kazuki [1 ]
Lu, Lien [1 ]
Zahorchak, Alan F. [1 ]
van der Windt, Dirk J. [1 ]
Dai, Helong [1 ]
Perez-Gutierrez, Angelica [1 ]
Bhama, Jay K. [2 ]
Thomson, Angus W. [1 ,3 ]
机构
[1] Univ Pittsburgh, Starzl Transplantat Inst, Dept Surg, Sch Med, 200 Lothrop St,Biomed Sci Tower, Pittsburgh, PA 15235 USA
[2] Univ Pittsburgh, Dept Cardiothorac Surg, Sch Med, Pittsburgh, PA 15235 USA
[3] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15235 USA
关键词
KIDNEY-TRANSPLANTATION; RABBIT ATG; REJECTION; THERAPY; PERSISTENCE; GENERATION; EXPANSION; RESPONSES; SUPPRESS; BIOLOGY;
D O I
10.1097/TP.0000000000003617
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Regulatory T cell (Treg) therapy is a promising approach to amelioration of allograft rejection and promotion of organ transplant tolerance. However, the fate of infused Treg, and how this relates to their therapeutic efficacy using different immunosuppressive regimens is poorly understood. Our aim was to analyze the tissue distribution, persistence, replicative activity and phenotypic stability of autologous, donor antigen alloreactive Treg (darTreg) in anti-thymocyte globulin (ATG)-lymphodepleted, heart-allografted cynomolgus monkeys. Methods. darTreg were expanded ex vivo from flow-sorted, circulating Treg using activated donor B cells and infused posttransplant into recipients of major histocompatibility complex-mismatched heart allografts. Fluorochrome-labeled darTreg were identified and characterized in peripheral blood, lymphoid, and nonlymphoid tissues and the graft by flow cytometric analysis. Results. darTreg selectively suppressed autologous T cell responses to donor antigens in vitro. However, following their adoptive transfer after transplantation, graft survival was not prolonged. Early (within 2 wk posttransplant; under ATG, tacrolimus, and anti-IL-6R) or delayed (6-8 wk posttransplant; under rapamycin) darTreg infusion resulted in a rapid decline in transferred darTreg in peripheral blood. Following their early or delayed infusion, labeled cells were evident in lymphoid and nonlymphoid organs and the graft at low percentages (<4% CD4(+) T cells). Notably, infused darTreg showed reduced expression of immunoregulatory molecules (Foxp3 and CTLA4), Helios, the proliferative marker Ki67 and antiapoptotic Bcl2, compared with preinfusion darTreg and endogenous CD4(+)CD25(hi) Treg. Conclusions. Lack of therapeutic efficacy of infused darTreg in lymphodepleted heart graft recipients appears to reflect loss of a regulatory signature and proliferative and survival capacity shortly after infusion.
引用
收藏
页码:1965 / 1979
页数:15
相关论文
共 40 条
[1]   Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates [J].
Bashuda, H ;
Kimikawa, M ;
Seino, K ;
Kato, Y ;
Ono, F ;
Shimizu, A ;
Yagita, H ;
Teraoka, S ;
Okumura, K .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (07) :1896-1902
[2]   Advances on CD8+ Treg Cells and Their Potential in Transplantation [J].
Bezie, Severine ;
Anegon, Ignacio ;
Guillonneau, Carole .
TRANSPLANTATION, 2018, 102 (09) :1467-1478
[3]   Type 1 diabetes immunotherapy using polyclonal regulatory T cells [J].
Bluestone, Jeffrey A. ;
Buckner, Jane H. ;
Fitch, Mark ;
Gitelman, Stephen E. ;
Gupta, Shipra ;
Hellerstein, Marc K. ;
Herold, Kevan C. ;
Lares, Angela ;
Lee, Michael R. ;
Li, Kelvin ;
Liu, Weihong ;
Long, S. Alice ;
Masiello, Lisa M. ;
Vinh Nguyen ;
Putnam, Amy L. ;
Rieck, Mary ;
Sayre, Peter H. ;
Tang, Qizhi .
SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (315)
[4]   Ex Vivo Expansion of Human Tregs by Rabbit ATG Is Dependent on Intact STAT3-Signaling in CD4+ T Cells and Requires the Presence of Monocytes [J].
Boenisch, O. ;
Lopez, M. ;
Elyaman, W. ;
Magee, C. N. ;
Ahmad, U. ;
Najafian, N. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (04) :856-866
[5]   Regulatory T Cells in Kidney Transplantation: New Directions? [J].
Braza, F. ;
Durand, M. ;
Degauque, N. ;
Brouard, S. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (09) :2288-2300
[6]   Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics [J].
Brunstein, Claudio G. ;
Miller, Jeffrey S. ;
Cao, Qing ;
McKenna, David H. ;
Hippen, Keli L. ;
Curtsinger, Julie ;
DeFor, Todd ;
Levine, Bruce L. ;
June, Carl H. ;
Rubinstein, Pablo ;
McGlave, Philip B. ;
Blazar, Bruce R. ;
Wagner, John E. .
BLOOD, 2011, 117 (03) :1061-1070
[7]   Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants [J].
Chandran, S. ;
Tang, Q. ;
Sarwal, M. ;
Laszik, Z. G. ;
Putnam, A. L. ;
Lee, K. ;
Leung, J. ;
Nguyen, V. ;
Sigdel, T. ;
Tavares, E. C. ;
Yang, J. Y. C. ;
Hellerstein, M. ;
Fitch, M. ;
Bluestone, J. A. ;
Vincenti, F. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (11) :2945-2954
[8]   Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells [J].
Dawson, Nicholas A. J. ;
Lamarche, Caroline ;
Hoeppli, Romy E. ;
Bergqvist, Peter ;
Fung, Vivian C. W. ;
McIver, Emma ;
Huang, Qing ;
Gillies, Jana ;
Speck, Madeleine ;
Orban, Paul C. ;
Bush, Jonathan W. ;
Mojibian, Majid ;
Levings, Megan K. .
JCI INSIGHT, 2019, 4 (06)
[9]   Non-Human Primate Regulatory T Cells: Current Biology and Implications for Transplantation [J].
Dons, Eefje M. ;
Raimondi, Giorgio ;
Cooper, David K. C. ;
Thomson, Angus W. .
TRANSPLANTATION, 2010, 90 (08) :811-816
[10]   Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients [J].
Ezzelarab, M. B. ;
Zhang, H. ;
Guo, H. ;
Lu, L. ;
Zahorchak, A. F. ;
Wiseman, R. W. ;
Nalesnik, M. A. ;
Bhama, J. K. ;
Cooper, D. K. C. ;
Thomson, A. W. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (07) :1999-2015